MAPP BIOPHARMACEUTICAL, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAPP BIOPHARMACEUTICAL, INC..The latest application filed is for "anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and use".

Company Profile

9.12.10

MAPP BIOPHARMACEUTICAL, INC. - San Diego CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,407,816 - Bornholdt , et al. August 9, 2	2022-08-09
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,407,817 - Bornholdt , et al. August 9, 2	2022-08-09
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,254,732 - Bornholdt , et al. February 22, 2	2022-02-22
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,242,379 - Bornholdt , et al. February 8, 2	2022-02-08
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,242,378 - Bornholdt , et al. February 8, 2	2022-02-08
Anti-crimean-congo Hemorrhagic Fever Virus Antibodies, And Methods Of Their Generation And Use App 20210355195 - Bornholdt; Zachary A. ; et al.	2021-11-18
Monoclonal antibodies and cocktails for treatment of ebola infections Grant 10,836,810 - Bornholdt , et al. November 17, 2	2020-11-17
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200354438 - Bornholdt; Zachary A. ; et al.	2020-11-12
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200354437 - Bornholdt; Zachary A. ; et al.	2020-11-12
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200299361 - Bornholdt; Zachary A. ; et al.	2020-09-24
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200299363 - Bornholdt; Zachary A. ; et al.	2020-09-24
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200299362 - Bornholdt; Zachary A. ; et al.	2020-09-24
Monoclonal Antibody Cocktails For Treatment Of Ebola Infections App 20190263894 - Hiatt; Andrew ; et al.	2019-08-29
Monoclonal Antibody Cocktails For Treatment Of Ebola Infections App 20190247501 - Hiatt; Andrew ; et al.	2019-08-15
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20180244758 - Bornholdt; Zachary A. ; et al.	2018-08-30
MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS App 20130149300 - Hiatt; Andrew ; et al.	2013-06-13

Company Registrations

NCAGE Code	417U0	MAPP BIOPHARMACEUTICAL, INC.
CAGE Code	417U0	MAPP BIOPHARMACEUTICAL, INC.
S.A.M. Registration	417U0 [137551797]	MAPP BIOPHARMACEUTICAL, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.